Cholesterol, HDL - Blood
Research News and Information

Sunday, November 22, 2009

Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study.

Nov 2009 OBJECTIVES: Our aim was to determine the effects of high-dose (2 g) nicotinic acid (NA) on progression of atherosclerosis and measures of vascular function. BACKGROUND: NA raises high-density lipoprotein cholesterol (HDL-C) and reduces low-density ... Read more...

Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.

24 Oct 2009 BACKGROUND: The role of high-density lipoprotein cholesterol (HDL-C) as a therapeutic target to prevent cardiovascular (CV) events remains unclear. We examined data from the Framingham Offspring Study from 1975 through 2003 to determine whether ... Read more...

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.

3 Oct 2009 A cluster of risk factors for cardiovascular disease and type 2 diabetes mellitus, which occur together more often than by chance alone, have become known as the metabolic syndrome. The risk factors include raised blood pressure, dyslipidemia ... Read more...

Latest indexed articles for 'Cholesterol, HDL - Blood'

These are the very latest articles for this heading:

• Assessing niacin as an atherosclerosis therapeutic agent valuable insights provided by high-resolution vascular magnetic resonance imaging. Nov 2009
• Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study. Nov 2009
• Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels. 24 Oct 2009
• Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. 3 Oct 2009
• Scavenger receptor class B type I mediates biliary cholesterol secretion independent of ATP-binding cassette transporter g5/g8 in mice. 29 Sep 2009
• Cardiovascular event risk: high-density lipoprotein and paraoxonase. 27 Sep 2009
• Paraoxonase variants relate to 10-year risk in coronary artery disease: impact of a high-density lipoprotein-bound antioxidant in secondary prevention. 27 Sep 2009
• Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study). 13 Sep 2009
• Acute effects of statin therapy on coronary atherosclerosis following an acute coronary syndrome. 13 Sep 2009
• ApoB versus non-HDL-C: what to do when they disagree. 30 Aug 2009
• The therapeutic potential of high-density lipoprotein mimetic agents in coronary artery disease. 30 Aug 2009
• Low HDL levels as the most common metabolic syndrome risk factor in heart failure. 30 Aug 2009
• Growth curves for cardio-metabolic risk factors in children and adolescents. 30 Aug 2009
• Patterns of change in cardiometabolic risk factors associated with the metabolic syndrome among children and adolescents: the Fels Longitudinal Study. 30 Aug 2009
• Stability of the factor structure of the metabolic syndrome across pubertal development: confirmatory factor analyses of three alternative models. 30 Aug 2009
• The relationship of ready-to-eat cereal consumption to nutrient intake, blood lipids, and body mass index of children as they age through adolescence. 30 Aug 2009
• Almonds lower LDL cholesterol. 30 Aug 2009
• A combination of proatherogenic single-nucleotide polymorphisms is associated with increased risk of coronary artery disease and myocardial infarction in Asian Indians. 30 Aug 2009
• Biochemical and nutritional indices as cardiovascular risk factors among Iranian firefighters. 18 Aug 2009
• Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans. 16 Aug 2009

See a longer list of these articles.

Technical information about 'Cholesterol, HDL'

Definition: Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol.

Registry Number: 0

Descriptor UI: D008076

Alternative terms: Cholesterol, HDL; High Density Lipoprotein Cholesterol; alpha-Lipoprotein Cholesterol; Cholesterol, alpha-Lipoprotein; alpha Lipoprotein Cholesterol; HDL Cholesterol; Cholesterol, HDL2; HDL(2) Cholesterol; HDL2 Cholesterol; Cholesterol, HDL3; HDL(3) Cholesterol; HDL3 Cholesterol;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;

Tree Number: D10.532.432.400; D10.570.938.208.270; D12.776.521.479.470;

History Note: 2007 (1985)